154 related articles for article (PubMed ID: 29120586)
21. Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Saad H; Zahran MA; Hendy O; Abdel-Samiee M; Bedair HM; Abdelsameea E
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3725-3734. PubMed ID: 33369474
[TBL] [Abstract][Full Text] [Related]
22. IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.
Zekri AR; Salama H; Medhat E; Bahnassy AA; Morsy HM; Lotfy MM; Ahmed R; Darwish T; Marei MS
Asian Pac J Cancer Prev; 2014; 15(17):7213-8. PubMed ID: 25227816
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants associated with the progression of hepatocellular carcinoma in hepatitis C Egyptian patients.
Motawi TK; Shaker OG; Ismail MF; Sayed NH
Gene; 2013 Sep; 527(2):516-20. PubMed ID: 23845776
[TBL] [Abstract][Full Text] [Related]
24. Gene deletion of glutathione S-transferase M1 and T1 and risk factors of hepatocellular carcinoma in Egyptian patients.
Abd El-Moneim E; Younis FA; Allam N; Gameel K; Osman M
Egypt J Immunol; 2008; 15(2):125-34. PubMed ID: 20306695
[TBL] [Abstract][Full Text] [Related]
25. Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease.
Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fumolo E; Fornasiere E; Bragagnini W; Pinato DJ; Minisini R; Pirisi M
Oncology; 2009; 77(5):304-13. PubMed ID: 19940521
[TBL] [Abstract][Full Text] [Related]
26. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
27. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence.
Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P
Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286
[TBL] [Abstract][Full Text] [Related]
28. Association Between Polymorphisms of Interleukin 1 Family Genes and Hepatocellular Carcinoma.
Tak KH; Yu GI; Lee MY; Shin DH
Med Sci Monit; 2018 May; 24():3488-3495. PubMed ID: 29802240
[TBL] [Abstract][Full Text] [Related]
29. IL12 Gene Polymorphism in Association with Hepatocellular Carcinoma in HCV-infected Egyptian Patients.
Elsayed HM; Nabiel Y; Sheta T
Immunol Invest; 2017 Feb; 46(2):123-133. PubMed ID: 27819525
[TBL] [Abstract][Full Text] [Related]
30. The toll-like receptor 2 (TLR2) -196 to -174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C.
Nischalke HD; Coenen M; Berger C; Aldenhoff K; Müller T; Berg T; Krämer B; Körner C; Odenthal M; Schulze F; Grünhage F; Nattermann J; Sauerbruch T; Spengler U
Int J Cancer; 2012 Mar; 130(6):1470-5. PubMed ID: 21500195
[TBL] [Abstract][Full Text] [Related]
31. Impact of cytokine gene variants on the prediction and prognosis of hepatocellular carcinoma in patients with cirrhosis.
Tarhuni A; Guyot E; Rufat P; Sutton A; Bourcier V; Grando V; Ganne-Carrié N; Ziol M; Charnaux N; Beaugrand M; Moreau R; Trinchet JC; Mansouri A; Nahon P
J Hepatol; 2014 Aug; 61(2):342-50. PubMed ID: 24751829
[TBL] [Abstract][Full Text] [Related]
32. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
33. Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis.
Charni F; Sutton A; Rufat P; Laguillier C; Mansouri A; Moreau R; Ganne-Carrié N; Trinchet JC; Beaugrand M; Charnaux N; Nahon P
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1439-46. PubMed ID: 21610221
[TBL] [Abstract][Full Text] [Related]
34. Alleles and genotypes of polymorphisms of IL-18, TNF-α and IFN-γ are associated with a higher risk and severity of hepatocellular carcinoma (HCC) in Brazil.
Teixeira AC; Mendes CT; Marano LA; Deghaide NH; Secaf M; Elias J; Muglia V; Donadi EA; Martinelli AL
Hum Immunol; 2013 Aug; 74(8):1024-9. PubMed ID: 23632060
[TBL] [Abstract][Full Text] [Related]
35. Programmed death-ligand 1 (PD-L1) polymorphisms as predictive biomarkers for the development of liver cirrhosis and hepatocellular carcinoma in HCV Egyptian patients.
Hassan M; Attia MS; Ali-Eldin Z; El Attar G; Elzallat M; Saad HHK; Isaac A
Tumour Virus Res; 2022 Dec; 14():200249. PubMed ID: 36265835
[TBL] [Abstract][Full Text] [Related]
36. Effect of CD133 polymorphisms on the risk of developing liver cirrhosis and hepatocellular carcinoma induced by viral hepatitis.
Hassan M; Nasr SM; Elzallat M
Virus Res; 2022 Apr; 312():198714. PubMed ID: 35181408
[TBL] [Abstract][Full Text] [Related]
37. Association of single nucleotide polymorphisms in microRNAs with susceptibility to hepatitis B virus infection and HBV-related liver complications: A study in a Saudi Arabian population.
Al-Qahtani AA; Al-Anazi MR; Nazir N; Wani K; Abdo AA; Sanai FM; Khan MQ; Al-Ashgar HI; Albenmousa A; Al-Hamoudi WK; Alswat KA; Al-Ahdal MN
J Viral Hepat; 2017 Dec; 24(12):1132-1142. PubMed ID: 28685993
[TBL] [Abstract][Full Text] [Related]
38. Impacts of TCF7L2 gene polymorphisms on the susceptibility of hepatogenous diabetes and hepatocellular carcinoma in cirrhotic patients.
Ling Q; Dong F; Geng L; Liu Z; Xie H; Xu X; Zheng S
Gene; 2013 Jun; 522(2):214-8. PubMed ID: 23558246
[TBL] [Abstract][Full Text] [Related]
39. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
Zhang QX; Yao YQ; Li SL; Long Q
Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
[TBL] [Abstract][Full Text] [Related]
40. The role of PRDM1 gene polymorphism in the progression of hepatocellular carcinoma in Egyptian patients.
Mohamed AA; Esmail OE; Ibrahim AMA; Makled S; Al-Hussain E; Elsaid A; Alboraie M; El-Awady RR
J Med Virol; 2023 Jan; 95(1):e28343. PubMed ID: 36424348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
